Your browser doesn't support javascript.
loading
Study on biomarker of Tripterygium wilfordii in treatment of rheumatoid arthritis based on PK/PD / 中国中药杂志
Article in Zh | WPRIM | ID: wpr-305298
Responsible library: WPRO
ABSTRACT
To observe the serum samples and the anti-inflammatory effect of Tripterygium wilfordii in treating RA by using the pharmacokinetic-pharmacodynamic model, make a correlation analysis on concentration-time and effect-time curves, and explore RORγt, IL-17, STAT3, IL-6 mRNA transcriptional levels in rats by PCR. Methotrexate, tripterine and high-dose T. wilfordii could down-regulate RORγt, IL-17, STAT3, IL-6 mRNA transcriptional levels in AA rat lymph nodes. The study on PK-PD model showed correlations between inflammatory factors and blood concentration of T. wilfordii. T. wilfordii and its main active constituent tripterine could show the inflammatory effect and treat RA by inhibiting IL-17 cytokine.
Subject(s)
Full text: 1 Index: WPRIM Main subject: Pharmacology / Arthritis, Rheumatoid / Triterpenes / Pharmacokinetics / Biomarkers / Interleukin-6 / Rats, Sprague-Dawley / Interleukin-17 / Tripterygium / Drug Therapy Type of study: Prognostic_studies Limits: Animals Language: Zh Journal: China Journal of Chinese Materia Medica Year: 2015 Type: Article
Full text: 1 Index: WPRIM Main subject: Pharmacology / Arthritis, Rheumatoid / Triterpenes / Pharmacokinetics / Biomarkers / Interleukin-6 / Rats, Sprague-Dawley / Interleukin-17 / Tripterygium / Drug Therapy Type of study: Prognostic_studies Limits: Animals Language: Zh Journal: China Journal of Chinese Materia Medica Year: 2015 Type: Article